Furthermore, resveratrol induced β-TrCP-mediated TWIST1 degradation to attenuate AKT inhibitor MK-2206-induced EMT in breast cancer and that AKT1/PKBα serves as a negative regulator of EMT and breast cancer metastasis [212]. Here, BTRC is linked to breast cancer.